2011
DOI: 10.1016/j.bmc.2011.02.050
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines

Abstract: An efficient method for the synthesis of N(9)-[3-fluoro-2-(phosphonomethoxy)propyl] (FPMP) derivatives of purine bases has been developed. Both (R)- and (S)-enantiomers of the N(6)-substituted FPMP derivatives of adenine and 2,6-diaminopurine were prepared and their anti-human immunodeficiency virus (HIV) and anti-Moloney murine sarcoma virus (MSV) activity was evaluated. Whereas none of the 6-substituted FPMPA derivatives showed any antiviral activity, several FPMPDAP derivatives had a moderate antiretroviral… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
18
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 27 publications
(19 citation statements)
references
References 39 publications
1
18
0
Order By: Relevance
“…Compared to the original laborious procedure, an efficient method for the synthesis of N 9 -[3-fluoro-2-(phosphonomethoxy)propyl] (FPMP) derivatives of purine bases was developed in 2011 by Janeba and coworkers [116]. Both (R)-and (S)-enantiomers of the N-6 substituted FPMP derivatives of adenine and 2,6-diaminopurine were prepared and their anti-HIV and antiMoloney murine sarcoma virus (MSV) activity was evaluated.…”
Section: Acyclic Nucleoside Phosphonatesmentioning
confidence: 99%
“…Compared to the original laborious procedure, an efficient method for the synthesis of N 9 -[3-fluoro-2-(phosphonomethoxy)propyl] (FPMP) derivatives of purine bases was developed in 2011 by Janeba and coworkers [116]. Both (R)-and (S)-enantiomers of the N-6 substituted FPMP derivatives of adenine and 2,6-diaminopurine were prepared and their anti-HIV and antiMoloney murine sarcoma virus (MSV) activity was evaluated.…”
Section: Acyclic Nucleoside Phosphonatesmentioning
confidence: 99%
“…Recently, we and others have employed phosphonate esters of fluorohydrin precursors 2a/b (Scheme 1) as convenient chiral starting materials in the synthesis of enantiomerically pure FPMPs bearing natural nucleobases. [15,16] Likewise, 6-chloropurine (1) was reacted under Mitsunobu conditions (Ph 3 P, DIAD) with precursors 2a/b to provide compounds 3a/b along with the concomitant formation of the corresponding triphenylphosphine adducts. However, by refluxing the crude reaction mixtures for 24 h in water, the undesired adducts were successfully hydrolyzed leading to the isolation of compounds 3a/b in excellent yields over two steps.…”
Section: Chemistrymentioning
confidence: 99%
“…Recently, Baszczyňski et al prepared series of both ( R )‐ and ( S )‐enantiomers of the N 6 ‐substituted FPMP derivatives of adenine (FPMPA, 120 , Fig. ) and 2,6‐diaminopurine (FPMPDAP, 121 ) for their subsequent biological evaluation.…”
Section: Acyclic Nucleoside Phosphonatesmentioning
confidence: 99%
“…The N 6 ‐substituted FPMPA analogues 120 displayed no activity against the viruses tested. On the other hand, several N 6 ‐substituted FPMPDAP derivatives 121 showed moderate anti‐HIV/MSV activity at subtoxic concentrations, although even the best analogues (i.e., N 6 ‐cyclopropyl and N 6 ‐allyl derivatives with EC 50 = 14.2 μM and EC 50 = 18.0 μM, respectively, against HIV‐1) proved three to four times less active than the parent ( R )‐FPMPDAP . They were also shown to act as prodrugs of the antiretroviral FPMPG analogues.…”
Section: Acyclic Nucleoside Phosphonatesmentioning
confidence: 99%
See 1 more Smart Citation